Involvement of periostin-sclerostin-Wnt/β-catenin signaling pathway in the prevention of neurectomy-induced bone loss by naringin

Biochemical and Biophysical Research Communications

Volumn 468, Issue 4, 2015, Pages 587-593

  Lv, Jianwei ^a,b   Sun, Xiaolei ^a   Ma, Jianxiong ^a   Ma, Xinlong ^a,b   Xing, Guosheng ^a   Wang, Ying ^a   Sun, Lei ^a   Wang, Jianbao ^a   Li, Fengbo ^a   Li, Yanjun ^a  

^a TIANJIN HOSPITAL   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Disuse osteoporosis; Naringin; Periostin; Sclerostin; catenin

Indexed keywords

AURANTIIN; BETA CATENIN; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; MESSENGER RNA; SCLEROSTIN; TRANSCRIPTION FACTOR RUNX2; WNT PROTEIN; BONE MORPHOGENETIC PROTEIN; CELL ADHESION MOLECULE; FLAVANONE DERIVATIVE; GENETIC MARKER; POSTN PROTEIN, RAT; SOST PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE CHARACTERISTICS AND FUNCTIONS; BONE DENSITY; BONE STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; FEMUR METAPHYSIS; MALE; NEURECTOMY; NONHUMAN; OSSIFICATION; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SIGNAL TRANSDUCTION; TRABECULAR BONE; UPREGULATION; ADVERSE EFFECTS; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; GENETIC MARKER; METABOLISM; NEUROSURGERY; SPRAGUE DAWLEY RAT; SURGERY; TREATMENT OUTCOME; WNT SIGNALING PATHWAY;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL ADHESION MOLECULES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; GENETIC MARKERS; MALE; NEUROSURGICAL PROCEDURES; OSTEOPOROSIS; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; TREATMENT OUTCOME; WNT SIGNALING PATHWAY;

EID: 84949595516     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.10.152     Document Type: Article

References (29)

1. S. Bharti, N. Rani, B. Krishnamurthy, and et al. Preclinical evidence for the pharmacological actions of naringin: a review Planta Med. 80 2014 437 451
2. F. Li, X. Sun, J. Ma, and et al. Naringin prevents ovariectomy-induced osteoporosis and promotes osteoclasts apoptosis through the mitochondria-mediated apoptosis pathway Biochem. Biophys. Res. Commun. 452 2014 629 635
3. H.Y. Yoon, Y.S. Cho, Q. Jin, and et al. Effects of ethyl acetate extract of poncirus trifoliata fruit for glucocorticoid-induced osteoporosis Biomol. Ther. Seoul 20 2012 89 95
4. M. Wei, Z. Yang, P. Li, and et al. Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model Am. J. Chin. Med. 35 2007 663 667
5. K. Mandadi, M. Ramirez, G.K. Jayaprakasha, and et al. Citrus bioactive compounds improve bone quality and plasma antioxidant activity in orchidectomized rats Phytomedicine 16 2009 513 520
6. V. Habauzit, S.M. Sacco, A. Gil-Izquierdo, and et al. Differential effects of two citrus flavanones on bone quality in senescent male rats in relation to their bioavailability and metabolism Bone 49 2011 1108 1116
7. N. Li, Y. Jiang, P.H. Wooley, and et al. Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis J. Orthop. Sci. 18 2013 478 485
8. J.B. Wu, Y.C. Fong, H.Y. Tsai, and et al. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts Eur. J. Pharmacol. 588 2008 333 341
9. E.S. Ang, X. Yang, H. Chen, and et al. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-kappaB and ERK activation FEBS Lett. 585 2011 2755 2762
10. K.C. Wong, W.Y. Pang, X.L. Wang, and et al. Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone Br. J. Nutr. 110 2013 475 485
11. Y. Wang, Y.P. Li, C. Paulson, and et al. Wnt and the Wnt signaling pathway in bone development and disease Front. Biosci. Landmark Ed. 19 2014 379 407
12. M. Rossini, D. Gatti, and S. Adami Involvement of WNT/beta-catenin signaling in the treatment of osteoporosis Calcif. Tissue Int. 93 2013 121 132
13. I. Kramer, C. Halleux, H. Keller, and et al. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis Mol. Cell. Biol. 30 2010 3071 3085
14. C. Lin, X. Jiang, Z. Dai, and et al. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling J. Bone Miner. Res. 24 2009 1651 1661
15. A.G. Robling, P.J. Niziolek, L.A. Baldridge, and et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin J. Biol. Chem. 283 2008 5866 5875
16. M. Gerbaix, L. Vico, S.L. Ferrari, and et al. Periostin expression contributes to cortical bone loss during unloading Bone 71 2015 94 100
17. N. Bonnet, K.N. Standley, E.N. Bianchi, and et al. The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity J. Biol. Chem. 284 2009 35939 35950
18. D. Wang, W. Ma, F. Wang, and et al. Stimulation of Wnt/beta-catenin signaling to improve bone development by naringin via Interacting with AMPK and Akt Cell. Physiol. Biochem. 36 2015 1563 1576
19. W.S. Kingery, S.C. Offley, T.Z. Guo, and et al. A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section Bone 33 2003 927 936
20. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
21. J.A. Robinson, M. Chatterjee-Kishore, P.J. Yaworsky, and et al. Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone J. Biol. Chem. 281 2006 31720 31728
22. M.P. Akhter, D.J. Wells, S.J. Short, and et al. Bone biomechanical properties in LRP5 mutant mice Bone 35 2004 162 169
23. K. Sawakami, A.G. Robling, M. Ai, and et al. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment J. Biol. Chem. 281 2006 23698 23711
24. K.E. Poole, R.L. van Bezooijen, N. Loveridge, and et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation FASEB J. 19 2005 1842 1844
25. M. Semenov, K. Tamai, and X. He SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor J. Biol. Chem. 280 2005 26770 26775
26. J.M. Spatz, R. Ellman, A.M. Cloutier, and et al. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading J. Bone Miner. Res. 28 2013 865 874
27. A.R. de Sousa, L.O. Penalva, E.M. Marcotte, and et al. Global signatures of protein and mRNA expression levels Mol. Biosyst. 5 2009 1512 1526
28. K. Horiuchi, N. Amizuka, S. Takeshita, and et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta J. Bone Miner. Res. 14 1999 1239 1249
29. N. Bonnet, S.J. Conway, and S.L. Ferrari Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin Proc. Natl. Acad. Sci. U. S. A. 109 2012 15048 15053